Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Amiodarone market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Amiodarone market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Amiodarone market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Amiodarone products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Amiodarone products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Amiodarone market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Amiodarone development has been the leading industry trend of Amiodarone market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Amiodarone Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Tablet, Capsule, Injection, Other |
| By Application Outlook |
Cardiac Arrest, Ventricular Tachycardia, Atrial Fibrillation, Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Sanofi, Sawai Pharmaceutical, Wyeth Pharmaceuticals (Pfizer), Mylan Pharmaceuticals, Arrow Pharma Pty Ltd, Roemmers, Cipla Pharmaceutical, Shanghai Pharmaceuticals, North China Pharmaceutical Company, Harbin Pharmaceutical Group |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Sanofi
- Sawai Pharmaceutical
- Wyeth Pharmaceuticals (Pfizer)
- Mylan Pharmaceuticals
- Arrow Pharma Pty Ltd
- Roemmers
- Cipla Pharmaceutical
- Shanghai Pharmaceuticals
- North China Pharmaceutical Company
- Harbin Pharmaceutical Group
AMIODARONE Market, By Type
- Tablet
- Capsule
- Injection
- Other
AMIODARONEMarket, By Application
- Cardiac Arrest
- Ventricular Tachycardia
- Atrial Fibrillation
- Others
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Amiodarone Market Overview
1.1 Amiodarone Product Overview
1.2 Amiodarone Market Segment by Type
1.2.1 Tablet
1.2.2 Capsule
1.2.3 Injection
1.3 Global Amiodarone Market Size by Type
1.3.1 Global Amiodarone Sales and Growth by Type
1.3.2 Global Amiodarone Sales and Market Share by Type (2013-2018)
1.3.3 Global Amiodarone Revenue and Market Share by Type (2013-2018)
1.3.4 Global Amiodarone Price by Type (2013-2018)
2 Global Amiodarone Market Competition by Company
2.1 Global Amiodarone Sales and Market Share by Company (2013-2018)
2.2 Global Amiodarone Revenue and Share by Company (2013-2018)
2.3 Global Amiodarone Price by Company (2013-2018)
2.4 Global Top Players Amiodarone Manufacturing Base Distribution, Sales Area, Product Types
2.5 Amiodarone Market Competitive Situation and Trends
2.5.1 Amiodarone Market Concentration Rate
2.5.2 Global Amiodarone Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Amiodarone Company Profiles and Sales Data
3.1 Sanofi
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Amiodarone Product Category, Application and Specification
3.1.3 Sanofi Amiodarone Sales, Revenue, Price and Gross Margin(2013-2018)
3.1.4 Main Business Overview
3.2 Sawai Pharmaceutical
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Amiodarone Product Category, Application and Specification
3.2.3 Sawai Pharmaceutical Amiodarone Sales, Revenue, Price and Gross Margin(2013-2018)
3.2.4 Main Business Overview
3.3 Wyeth Pharmaceuticals (Pfizer)
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Amiodarone Product Category, Application and Specification
3.3.3 Wyeth Pharmaceuticals (Pfizer) Amiodarone Sales, Revenue, Price and Gross Margin(2013-2018)
3.3.4 Main Business Overview
3.4 Mylan Pharmaceuticals
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Amiodarone Product Category, Application and Specification
3.4.3 Mylan Pharmaceuticals Amiodarone Sales, Revenue, Price and Gross Margin(2013-2018)
3.4.4 Main Business Overview
3.5 Arrow Pharma Pty Ltd
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Amiodarone Product Category, Application and Specification
3.5.3 Arrow Pharma Pty Ltd Amiodarone Sales, Revenue, Price and Gross Margin(2013-2018)
3.5.4 Main Business Overview
3.6 Roemmers
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Amiodarone Product Category, Application and Specification
3.6.3 Roemmers Amiodarone Sales, Revenue, Price and Gross Margin(2013-2018)
3.6.4 Main Business Overview
3.7 Cipla Pharmaceutical
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Amiodarone Product Category, Application and Specification
3.7.3 Cipla Pharmaceutical Amiodarone Sales, Revenue, Price and Gross Margin(2013-2018)
3.7.4 Main Business Overview
3.8 Shanghai Pharmaceuticals
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Amiodarone Product Category, Application and Specification
3.8.3 Shanghai Pharmaceuticals Amiodarone Sales, Revenue, Price and Gross Margin(2013-2018)
3.8.4 Main Business Overview
3.9 North China Pharmaceutical Company
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Amiodarone Product Category, Application and Specification
3.9.3 North China Pharmaceutical Company Amiodarone Sales, Revenue, Price and Gross Margin(2013-2018)
3.9.4 Main Business Overview
3.10 Harbin Pharmaceutical Group
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Amiodarone Product Category, Application and Specification
3.10.3 Harbin Pharmaceutical Group Amiodarone Sales, Revenue, Price and Gross Margin(2013-2018)
3.10.4 Main Business Overview
4 Amiodarone Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Amiodarone Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Amiodarone Sales and Revenue by Regions
4.2.1 Global Amiodarone Sales and Market Share by Regions (2013-2018)
4.2.2 Global Amiodarone Revenue and Market Share by Regions (2013-2018)
4.2.3 Global Amiodarone Sales, Revenue, Price and Gross Margin (2013-2018)
4.3 North America Amiodarone Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Amiodarone Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Amiodarone Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Amiodarone Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Amiodarone Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Amiodarone Application/End Users
5.1 Amiodarone Segment by Application
5.1.1 Cardiac Arrest
5.1.2 Ventricular Tachycardia
5.1.3 Atrial Fibrillation
5.1.4 Others
5.2 Global Amiodarone Product Segment by Application
5.2.1 Global Amiodarone Sales by Application
5.2.2 Global Amiodarone Sales and Market Share by Application (2013-2018)
6 Global Amiodarone Market Forecast
6.1 Global Amiodarone Sales, Revenue Forecast (2018-2025)
6.1.1 Global Amiodarone Sales and Growth Rate Forecast (2018-2025)
6.1.1 Global Amiodarone Revenue and Growth Rate Forecast (2018-2025)
6.2 Global Amiodarone Forecast by Regions
6.2.1 North America Amiodarone Sales and Revenue Forecast (2018-2025)
6.2.2 Europe Amiodarone Sales and Revenue Forecast (2018-2025)
6.2.3 Asia-Pacific Amiodarone Sales and Revenue Forecast (2018-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Amiodarone Sales and Revenue Forecast (2018-2025)
6.2.5 Middle East and Africa Amiodarone Sales and Revenue Forecast (2018-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Amiodarone Forecast by Type
6.3.1 Global Amiodarone Sales and Revenue Forecast by Type (2018-2025)
6.3.2 Tablet Gowth Forecast
6.3.3 Capsule Gowth Forecast
6.4 Amiodarone Forecast by Application
6.4.1 Global Amiodarone Sales Forecast by Application (2018-2025)
6.4.2 Global Amiodarone Forecast in Cardiac Arrest
6.4.3 Global Amiodarone Forecast in Ventricular Tachycardia
7 Amiodarone Upstream Raw Materials
7.1 Amiodarone Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Amiodarone Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
